Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 10 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT04718051Phase 4
- FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisStatus unknownNCT04710524Phase 2
- Multiple Ascending Dose Study of HU6 in High BMI VolunteersCompletedNCT04709913Phase 1
- Formula Diet Treatment for NASH Patients.Active, not recruitingNCT04707651Not applicable
- Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)CompletedNCT04704063Phase 2
- Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASHStatus unknownNCT04702490Phase 2
- Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLDCompletedNCT04698486Not applicable
- Cigarette Smoking in Non-alcoholic SteatohepatitisCompletedNCT04688307Not applicable
- The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFFCompletedNCT04682600Not applicable
- Statins for the Treatment of NASHActive, not recruitingNCT04679376Phase 2
- Liquid Biopsy for NASH and Liver FibrosisCompletedNCT04677101
- Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With FibroscanCompletedNCT04671186Not applicable
- Bariatric Endoscopy and NAFLDStatus unknownNCT04669470Not applicable
- Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.Status unknownNCT04653311Not applicable
- NASH in Subjects With Different Classes of ObesityStatus unknownNCT04653103
- Screening for NAFLD in FlandersActive, not recruitingNCT04647409Not applicable
- Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control SubjectsCompletedNCT04643795Phase 1
- Effect of Empagliflozin on Liver Fat in Non-diabetic PatientsCompletedNCT04642261Phase 4
- Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.CompletedNCT04640324Not applicable
- Combined Active Treatment in Type 2 Diabetes With NASHCompletedNCT04639414Phase 4
- Combi-elastography Assessment of Chronic Liver Disease Multi-center StudyStatus unknownNCT04625166
- Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"CompletedNCT04616664
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver FibrosisWithdrawnNCT04607655Phase 1/2
- Early Vascular Ageing in the YOUthCompletedNCT04598685
- Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesActive, not recruitingNCT04595474
- Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT04594954Not applicable
- Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRECompletedNCT04591106
- Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.CompletedNCT04579874Not applicable
- Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty LiverCompletedNCT04575506Not applicable
- Micro RNA Levels in NAFLDStatus unknownNCT04574557
- The Role of Immune Semaphorins in NAFLDCompletedNCT04573543
- Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After OptimizationCompletedNCT04571957
- A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)TerminatedNCT04565717Phase 1
- Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian PatientsCompletedNCT04561895
- ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and TolerabilityCompletedNCT04561245Phase 1
- A Study of EDP-297 in Healthy SubjectsCompletedNCT04559126Phase 1
- Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASHCompletedNCT04555434Phase 1/2
- Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.Status unknownNCT04553796
- Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese PopulationCompletedNCT04551716
- Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult SubjectsCompletedNCT04546984Phase 1
- 24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD PatientsStatus unknownNCT04543721
- Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)CompletedNCT04537780Phase 4
- Serum Irisin Levels in Obese ChildrenCompletedNCT04524936
- Ultrasound Quantification of Liver FatCompletedNCT04523584
- Functional Roll for Non-alcoholic Fatty Liver DiseaseCompletedNCT04520724Not applicable
- The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 DiabetesCompletedNCT04509245Not applicable
- Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)CompletedNCT04505436Phase 2
- Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric SurgeryStatus unknownNCT04501042
- A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis PatientsCompletedNCT04483947Phase 1
- Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut University HospitalsStatus unknownNCT04482153
- A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy SubjectsStatus unknownNCT04481594Phase 1
- Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver DiseasesCompletedNCT04475276Phase 4
- The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT04465032Phase 4
- Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver DiseaseActive, not recruitingNCT04463667Not applicable
- Ascending Dose Study of HU6 in Healthy VolunteersCompletedNCT04463017Phase 1
- Quantitative US for Evaluation of Hepatic Steatosis in NAFLDCompletedNCT04462562Not applicable
- Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes PatientsCompletedNCT04462081
- Nonalcoholic Fatty Liver Disease (NAFLD) Database 3CompletedNCT04454463
- Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser TherapyCompletedNCT04452409Not applicable
- Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLDCompletedNCT04450875Not applicable
- Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical ActivityStatus unknownNCT04442620Not applicable
- Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based StudyTerminatedNCT04440540Not applicable
- Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.CompletedNCT04435054Not applicable
- The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy SubjectsCompletedNCT04422496Phase 1
- Mediterranean Diet Treatment for NAFLDCompletedNCT04415112Not applicable
- Efficacy of Phosphatidylcholine in NAFLDCompletedNCT04411862Phase 3
- Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver DiseaseStatus unknownNCT04400864Not applicable
- Effects of ACC Inhibitor on Lipid and Lipoprotein MetabolismWithdrawnNCT04395950Phase 1
- To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult ParticipantsCompletedNCT04389775Phase 1
- Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As ReferenceCompletedNCT04389593
- Combination Diagnostic Strategies in NAFLDCompletedNCT04384159
- Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH CirrhosisActive, not recruitingNCT04383951Not applicable
- A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver DiseaseWithdrawnNCT04371653Phase 2
- Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 InfectionCompletedNCT04369807
- Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT04369521Not applicable
- Sulforaphane Supplementation StudyStatus unknownNCT04364360Not applicable
- Intermittent Fasting in Nonalcoholic Fatty Liver DiseaseStatus unknownNCT04355910Not applicable
- A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASHCompletedNCT04342793Phase 2
- Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)CompletedNCT04341246
- Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry)CompletedNCT04336800
- Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex PopulationCompletedNCT04336618
- Metabolic Cofactor Supplementation in Obese Patients with Non-Alcoholic Fatty Liver DiseaseCompletedNCT04330326Phase 2
- The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin ResistanceTerminatedNCT04315350Not applicable
- Safety and Tolerability of Novel Medical Nutrition Products for NAFLD TreatmentStatus unknownNCT04308980Phase 2/3
- Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudySuspendedNCT04306939
- Assessment of Fatty Liver With Thermo-acoustic DeviceWithdrawnNCT04302051
- Bariatric Surgery vs. Lifestyle Modification for NASHStatus unknownNCT04298736Not applicable
- Splanchnic and Systemic VLDL-TG and FFA BalanceCompletedNCT04292977
- Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic SubjectsCompletedNCT04285554Not applicable
- The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric PatientsTerminatedNCT04284371
- Screening of NASH in Oupatients Followed in Various Hospital Specialty Clinics at the University Hospital of StrasbourgStatus unknownNCT04282447
- Metabolic Surgery for Steato-HepatitisStatus unknownNCT04282005Not applicable
- Endoscopic Bariatric Therapy in NASH CirrhosisStatus unknownNCT04281303
- Omega 3 Supplementation in Children With Non Alcoholic Fatty LiverCompletedNCT04281121Not applicable
- A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and FibrosisStatus unknownNCT04255069Phase 2
- Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous FatStatus unknownNCT04240145
- Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseCompletedNCT04235205Phase 2
- Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes MellitusCompletedNCT04232293Not applicable
- Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric BalloonStatus unknownNCT04230655Not applicable
- MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)Active, not recruitingNCT04227782